Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$2.64
-1.68%
Mkt Cap $199.83M
Next Earnings
In 30 daysThu, May 28, 2026
EPS Estimate
-$0.73
5 analysts
Revenue Estimate
$948.01K
Last quarter: missed by -0.22% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$199.83M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.58